Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seock-Ah Im

Showing results (81-90 of 567) with videos related to

Pageof 57
Sort By:
Expert Opinion on Investigational Drugs|February 12, 2013
Concurrent celecoxib with 5-fluorouracil/epirubicin/cyclophosphamide followed by docetaxel for stages II - III invasive breast cancer: the OOTR-N001 studyLouis W C Chow, Stewart Y Tung, Ting-Ying Ng, et al.
Journal of Breast Cancer|January 6, 2017
Prognostic Significance of Inner Quadrant Involvement in Breast Cancer Treated with Neoadjuvant ChemotherapyJi Hyun Chang, Wan Jeon, Kyubo Kim, et al.
Journal of Surgical Oncology|October 24, 2012
Outcomes of surgery aiming at curative resection in good responder to induction chemotherapy for gastric cancer with distant metastasesDong-Seok Han, Yun-Suhk Suh, Seong-Ho Kong, et al.
Psychosomatic Medicine|July 19, 2016
Longitudinal Association of Poor Sleep Quality With Chemotherapy-Induced Nausea and Vomiting in Patients With Breast CancerDooyoung Jung, Kwang-Min Lee, Won-Hyoung Kim, et al.
Journal of Breast Cancer|April 12, 2012
A case report of breast cancer with extensive pulmonary lymphovascular tumor emboliYaewon Yang, Younak Choi, Seung Hoon Beom, et al.
European Journal of Cancer (Oxford, England : 1990)|December 24, 2013
Genetic polymorphisms of SLC28A3, SLC29A1 and RRM1 predict clinical outcome in patients with metastatic breast cancer receiving gemcitabine plus paclitaxel chemotherapySoo-Youn Lee, Seock-Ah Im, Yeon Hee Park, et al.
Molecular Cancer Therapeutics|September 21, 2018
Androgen Receptor Inhibitor Enhances the Antitumor Effect of PARP Inhibitor in Breast Cancer Cells by Modulating DNA Damage ResponseAhrum Min, Hyemin Jang, Seongyeong Kim, et al.
Tumori|July 27, 2011
Concurrent versus sequential administration of CMF chemotherapy and radiotherapy after breast-conserving surgery in early breast cancerKyubo Kim, Eui Kyu Chie, Wonshik Han, et al.
American Journal of Clinical Oncology|August 26, 2009
Prognostic factors affecting the outcome of salvage radiotherapy for isolated locoregional recurrence after mastectomyKyubo Kim, Eui Kyu Chie, Wonshik Han, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 16, 2007
Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapyYeonjoo Jung, Jinah Park, Tai Young Kim, et al.
Pageof 57

Showing results (81-90 of 567) with videos related to

Sort By:
Pageof 57
Expert Opinion on Investigational Drugs|February 12, 2013
Concurrent celecoxib with 5-fluorouracil/epirubicin/cyclophosphamide followed by docetaxel for stages II - III invasive breast cancer: the OOTR-N001 studyLouis W C Chow, Stewart Y Tung, Ting-Ying Ng, et al.
Journal of Breast Cancer|January 6, 2017
Prognostic Significance of Inner Quadrant Involvement in Breast Cancer Treated with Neoadjuvant ChemotherapyJi Hyun Chang, Wan Jeon, Kyubo Kim, et al.
Journal of Surgical Oncology|October 24, 2012
Outcomes of surgery aiming at curative resection in good responder to induction chemotherapy for gastric cancer with distant metastasesDong-Seok Han, Yun-Suhk Suh, Seong-Ho Kong, et al.
Psychosomatic Medicine|July 19, 2016
Longitudinal Association of Poor Sleep Quality With Chemotherapy-Induced Nausea and Vomiting in Patients With Breast CancerDooyoung Jung, Kwang-Min Lee, Won-Hyoung Kim, et al.
Journal of Breast Cancer|April 12, 2012
A case report of breast cancer with extensive pulmonary lymphovascular tumor emboliYaewon Yang, Younak Choi, Seung Hoon Beom, et al.
European Journal of Cancer (Oxford, England : 1990)|December 24, 2013
Genetic polymorphisms of SLC28A3, SLC29A1 and RRM1 predict clinical outcome in patients with metastatic breast cancer receiving gemcitabine plus paclitaxel chemotherapySoo-Youn Lee, Seock-Ah Im, Yeon Hee Park, et al.
Molecular Cancer Therapeutics|September 21, 2018
Androgen Receptor Inhibitor Enhances the Antitumor Effect of PARP Inhibitor in Breast Cancer Cells by Modulating DNA Damage ResponseAhrum Min, Hyemin Jang, Seongyeong Kim, et al.
Tumori|July 27, 2011
Concurrent versus sequential administration of CMF chemotherapy and radiotherapy after breast-conserving surgery in early breast cancerKyubo Kim, Eui Kyu Chie, Wonshik Han, et al.
American Journal of Clinical Oncology|August 26, 2009
Prognostic factors affecting the outcome of salvage radiotherapy for isolated locoregional recurrence after mastectomyKyubo Kim, Eui Kyu Chie, Wonshik Han, et al.
Journal of Molecular Medicine (Berlin, Germany)|June 16, 2007
Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapyYeonjoo Jung, Jinah Park, Tai Young Kim, et al.
Pageof 57